Xenograft assessment of predictive biomarkers for standard head and neck cancer therapies

Head and neck squamous cell carcinoma (HNSCC) remains a challenging cancer to treat with overall 5-year survival on the order of 50–60%. Therefore, predictive biomarkers for this disease would be valuable to provide more effective and individualized therapeutic approaches for these patients. While p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer Med
Hauptverfasser: Stein, Andrew P, Swick, Adam D, Smith, Molly A, Blitzer, Grace C, Yang, Robert Z, Saha, Sandeep, Harari, Paul M, Lambert, Paul F, Liu, Cheng Z, Kimple, Randall J
Format: Artigo
Sprache:Inglês
Veröffentlicht: BlackWell Publishing Ltd 2015
Schlagworte:
Cancer Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4430263/
https://ncbi.nlm.nih.gov/pubmed/25619980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.387
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge